FRANKLYN G PRENDERGAST
CIK 1233256 · last filed 2023-10-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$78.53M
Companies
5
Total Filings
27
Lifetime Open-Market Net
$0
Filer Profile
Related Filers
LILLY & Co ELI — 11 joint filings, latest 2017-11-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMNM | Director | 60,840 | $24.97 | $1.52M | $0 | 4 | 2023-10-04 |
| NeuBase Therapeutics, Inc. (NBSE) Delisted | Director | — | $0.38 | — | $0 | 4 | 2022-09-12 |
| LTRN | Director | — | $1.76 | — | $0 | 2 | 2021-11-08 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | 12,500 | $4.61 | $57.6K | $0 | 6 | 2019-08-21 |
| LLY | Director | 68,574 | $1123.00 | $77.01M | $0 | 11 | 2017-11-22 |
Recent Filings · Page 3 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-15 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-03 | LLY | Grant (A) | +3,083 | $145.0K | EDGAR |
| 2011-12-01 | LLY | Grant (A) | +3,990 | $145.0K | EDGAR |
| 2010-12-01 | LLY | Grant (A) | +4,187 | $145.0K | EDGAR |
| 2009-12-01 | LLY | Grant (A) | +4,040 | $145.0K | EDGAR |
| 2008-12-02 | LLY | Grant (A) | +4,513 | $145.0K | EDGAR |
| 2007-12-03 | LLY | Grant (A) | +2,840 | $145.0K | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.